CORTISPORIN (hydrocortisone; neomycin sulfate; polymyxin b sulfate) by Monarch Therapeutics is clinical pharmacology colistin sulfate is a polypeptide antibiotic which penetrates into and disrupts the bacterial cell membrane. Approved for superficial bacterial infections of the external auditory canal, caused by organisms susceptible to the action of the antibiotics. First approved in 1975.
Drug data last refreshed 20h ago · AI intelligence enriched 2w ago
CORTISPORIN is a fixed-combination otic solution containing hydrocortisone (corticosteroid), neomycin sulfate, and polymyxin B sulfate (aminoglycoside and polypeptide antibiotics). It treats superficial bacterial infections of the external auditory canal caused by susceptible organisms including Staphylococcus aureus and gram-negative bacteria. The combination works by disrupting bacterial cell membranes and protein synthesis while reducing inflammation and pruritus.
As a legacy otic product approaching loss of exclusivity, the brand team is likely in transition mode with emphasis on cost management and lifecycle extension rather than growth initiatives.
CLINICAL PHARMACOLOGY Colistin sulfate is a polypeptide antibiotic which penetrates into and disrupts the bacterial cell membrane. Neomycin sulfate is an aminoglycoside antibiotic which inhibits protein synthesis, disrupting the normal cycle of ribosomal function. Hydrocortisone acetate is a…
Worked on CORTISPORIN at Monarch Therapeutics? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Working on CORTISPORIN offers limited career upside in a declining, commoditized market with no linked job openings. Professionals should expect focus on cost optimization, generic defense, and market maintenance rather than growth, innovation, or geographic expansion.